Splicing factor TRA2B is required for neural progenitor survival

Journal of Comparative Neurology

Volumn 522, Issue 2, 2014, Pages 372-392

  Roberts, Jacqueline M ^a   Ennajdaoui, Hanane ^a   Edmondson, Carina ^a   Wirth, Brunhilde ^b   Sanford, Jeremy R ^a   Chen, Bin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cerebral cortex; Development; Neural progenitor; Splicing; SR protein; TRA2B

Indexed keywords

PROTEIN TRA2B; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; FEMALE; MALE; MAMMAL; MOUSE; NERVE CELL; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING;

CEREBRAL CORTEX; DEVELOPMENT; NEURAL PROGENITOR; SPLICING; SR PROTEIN; TRA2B;

ALTERNATIVE SPLICING; ANIMALS; BLOTTING, WESTERN; CELL SURVIVAL; CEREBRAL CORTEX; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; NEURAL STEM CELLS; NEUROGENESIS; NEURONS; NUCLEAR PROTEINS; RNA-BINDING PROTEINS;

EID: 84889667906     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23405     Document Type: Article

References (93)

1. Adachi K, Suemori H, Yasuda S, Nakatsuji N, Kawase E. 2010. Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells 15:455-470.
2. Amrein H, Gorman M, Nöthiger R. 1988. The sex-determining gene tra-2 of Drosophila encodes a putative RNA binding protein. Cell 55:1025-1035.
3. Anderson ES, Lin C-H, Xiao X, Stoilov P, Burge CB, Black DL. 2012. The cardiotonic steroid digitoxin regulates alternative splicing through depletion of the splicing factors SRSF3 and TRA2B. RNA 18:1041-1049.
4. Angevine JB Jr, Sidman RL. 1961. Autoradiographic study of cell migration during histogenesis of cerebral cortex in the mouse. Nature 192:766-768.
5. Barbosa-Morais NL, Irimia M, Pan Q, Xiong HY, Gueroussov S, Lee LJ, Slobodeniuc V, Kutter C, Watt S, Çolak R, et al. 2012. The evolutionary landscape of alternative splicing in vertebrate species. Science 338:1587-1593.
6. Berry M, Rogers AW. 1965. The migration of neuroblasts in the developing cerebral cortex. J Anat 99:691-709.
7. Black DL. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72:291-336.
8. Blechingberg J, Holm IE, Nielsen AL. 2012. Characterization and expression analysis in the developing embryonic brain of the porcine FET family: FUS, EWS, and TAF15. Gene 493:27-35.
9. Boutz PL, Stoilov P, Li Q, Lin C-H, Chawla G, Ostrow K, Shiue L, Ares M Jr, Black DL. 2007. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 21:1636-1652.
10. Busch A, Hertel KJ. 2012. Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip Rev RNA 3:1-12.
11. Caffrey TM, Wade-Martins R. 2007. Functional MAPT haplotypes: bridging the gap between genotype and neuropathology. Neurobiol Dis 27:1-10.
12. Calarco JA, Zhen M, Blencowe BJ. 2011. Networking in a global world: establishing functional connections between neural splicing regulators and their target transcripts. RNA 17:775-791.
13. Califice S, Baurain D, Hanikenne M, Motte P. 2012. A Single ancient origin for prototypical serine/arginine-rich splicing factors. Plant Physiol 158:546-560.
14. Castle JC, Zhang C, Shah JK, Kulkarni AV, Kalsotra A, Cooper TA, Johnson JM. 2008. Expression of 24, 426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat Genet 40:1416-1425.
15. Caviness VS Jr, Takahashi T. 1995. Proliferative events in the cerebral ventricular zone. Brain Dev 17:159-163.
16. Cazalla D, Sanford JR, Cáceres JF. 2005. A rapid and efficient protocol to purify biologically active recombinant proteins from mammalian cells. Prot Express Purif 42:54-58.
17. Chen B, Schaevitz LR, McConnell SK. 2005. Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex. Proc Natl Acad Sci U S A 102:17184-17189.
18. Chen B, Wang SS, Hattox AM, Rayburn H, Nelson SB, McConnell SK. 2008. The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex. Proc Natl Acad Sci U S A 105:11382-11387.
19. Chen J-G, Rasin M-R, Kwan KY, Sestan N. 2005. Zfp312 is required for subcortical axonal projections and dendritic morphology of deep-layer pyramidal neurons of the cerebral cortex. Proc Natl Acad Sci U S A 102:17792-17797.
20. Chou S-J, Perez-Garcia CG, Kroll TT, O'Leary DDM. 2009. Lhx2 specifies regional fate in Emx1 lineage of telencephalic progenitors generating cerebral cortex. Nat Neurosci 12:1381-1389.
21. D'Souza I, Poorkaj P, Hong M, Nochlin D, Lee VM-Y, Bird TD, Schellenberg GD. 1999. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci U S A 96:5598-5603.
22. Daoud R, Da Penha Berzaghi M, Siedler F, Hübener M, Stamm S. 1999. Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur J Neurosci 11:788-802.
23. Dawson HN, Cantillana V, Chen L, Vitek MP. 2007. The Tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model. J Neurosci 27:9155-9168.
24. DeFelipe J. 1993. Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules. Cereb Cortex 3:273-289.
25. Diez-Roux G, Banfi S, Sultan M, Geffers L, Anand S, Rozado D, Magen A, Canidio E, Pagani M, Peluso I, et al. 2011. A high-resolution anatomical atlas of the transcriptome in the mouse embryo. PLoS Biol 9:e1000582.
26. Ding D, Xu H, Liang Q, Xu L, Zhao Y, Wang Y. 2012. Over-expression of Sox2 in C3H10T1/2 cells inhibits osteoblast differentiation through Wnt and MAPK signalling pathways. Int Orthop (SICOT) 36:1087-1094.
27. Eckler MJ, McKenna WL, Taghvaei S, McConnell SK, Chen B. 2011. Fezf1 and Fezf2 are required for olfactory development and sensory neuron identity. J Comp Neurol 519:1829-1846.
28. Elliott DJ, Best A, Dalgliesh C, Ehrmann I, Grellscheid S. 2012. How does Tra2β protein regulate tissue-specific RNA splicing? Biochem Soc Trans 40:784-788.
29. Eom T, Zhang C, Wang H, Lay K, Fak J, Noebels JL, Darnell RB. 2013. NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. Elife 2:e00178.
30. Garbes L, Heesen L, Hölker I, Bauer T, Schreml J, Zimmermann K, Thoenes M, Walter M, Dimos J, Peitz M, et al. 2013. VPA response in SMA is suppressed by the fatty acid translocase CD36. Hum Mol Genet 22:398-407.
31. Gorski JA, Talley T, Qiu M, Puelles L, Rubenstein JLR, Jones KR. 2002. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci 22:6309-6314.
32. Götz M, Huttner WB. 2005. The cell biology of neurogenesis. Nat Rev Mol Cell Biol 6:777-788.
33. Graveley BR, Maniatis T. 1998. Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol Cell 1:765-771.
34. Graveley BR, Hertel KJ, Maniatis T. 2001. The role of U2AF35 and U2AF65 in enhancer-dependent splicing. RNA 7:806-818.
35. Grellscheid S, Dalgliesh C, Storbeck M, Best A, Liu Y, Jakubik M, Mende Y, Ehrmann I, Curk T, Rossbach K, et al. 2011. Identification of evolutionarily conserved exons as regulated targets for the splicing activator Tra2β in development. PLoS Genet 7:e1002390.
36. Gulisano M, Broccoli V, Pardini C, Boncinelli E. 1996. Emx1 and Emx2 show different patterns of expression during proliferation and differentiation of the developing cerebral cortex in the mouse. Eur J Neurosci 8:1037-1050.
37. Han W, Kwan KY, Shim S, Lam MMS, Shin Y, Xu X, Zhu Y, Li M, Sestan N. 2011. TBR1 directly represses Fezf2 to control the laminar origin and development of the corticospinal tract. Proc Natl Acad Sci U S A 108:3041-3046.
38. Hansen DV, Lui JH, Parker PRL, Kriegstein AR. 2010. Neurogenic radial glia in the outer subventricular zone of human neocortex. Nature 464:554-561.
39. Hartmann AM, Rujescu D, Giannakouros T, Nikolakaki E, Goedert M, Mandelkow E-M, Gao QS, Andreadis A, Stamm S. 2001. Regulation of alternative splicing of human Tau exon 10 by phosphorylation of splicing factors. Mol Cell Neurosci 18:80-90.
40. Hayakawa H, Hayakawa M, Kume A, Tominaga S. 2007. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282:26369-26380.
41. Hoch RV, Rubenstein JLR, Pleasure S. 2009. Genes and signaling events that establish regional patterning of the mammalian forebrain. Semin Cell Dev Biol 20:378-386.
42. Hofmann Y, Wirth B. 2002. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-β1. Hum Mol Genet 11:2037-2049.
43. Hofmann Y, Lorson CL, Stamm S, Androphy EJ, Wirth B. 2000. Htra2-β1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci U S A 97:9618-9623.
44. Hutton SR, Pevny LH. 2011. SOX2 expression levels distinguish between neural progenitor populations of the developing dorsal telencephalon. Dev Biol 352:40-47.
45. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, et al. 1998. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705.
46. Izquierdo JM, Valcárcel J. 2007. Fas-activated serine/threonine kinase (FAST K) synergizes with TIA-1/TIAR proteins to regulate Fas alternative splicing. J Biol Chem 282:1539-1543.
47. Jellinger KA. 2012. Interaction between pathogenic proteins in neurodegenerative disorders. J Cell Mol Med 16:1166-1183.
48. Joshi PS, Molyneaux BJ, Feng L, Xie X, Macklis JD, Gan L. 2008. Bhlhb5 regulates the postmitotic acquisition of area identities in layers II-V of the developing neocortex. Neuron 60:258-272.
49. Kohtz JD, Jamison SF, Will CL, Zuo P, Lührmann R, Garcia-Blanco MA, Manley JL. 1994. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 368:119-124.
50. Kwan KY, Šestan N, Anton ES. 2012. Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex. Development 139:1535-1546.
51. Leone DP, Srinivasan K, Chen B, Alcamo E, McConnell SK. 2008. The determination of projection neuron identity in the developing cerebral cortex. Curr Opin Neurobiol 18:28-35.
52. Lewis BP, Green RE, Brenner SE. 2003. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci U S A 100:189-192.
53. Li Q, Lee J-A, Black DL. 2007. Neuronal regulation of alternative pre-mRNA splicing. Nat Rev Neurosci 8:819-831.
54. Long JC, Caceres JF. 2009. The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417:15.
55. Lopez AJ. 1998. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu Rev Genet 32:279-305.
56. McKenna WL, Betancourt J, Larkin KA, Abrams B, Guo C, Rubenstein JLR, Chen B. 2011. Tbr1 and Fezf2 regulate alternate corticofugal neuronal identities during neocortical development. J Neurosci 31:549-564.
57. Mende Y, Jakubik M, Riessland M, Schoenen F, Rossbach K, Kleinridders A, Köhler C, Buch T, Wirth B. 2010. Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing. Hum Mol Genet 19:2154-2167.
58. Merkin J, Russell C, Chen P, Burge CB. 2012. Evolutionary dynamics of gene and isoform regulation in mammalian tissues. Science 338:1593-1599.
59. Migliore M, Shepherd GM. 2005. Opinion: an integrated approach to classifying neuronal phenotypes. Nat Rev Neurosci 6:810-818.
60. Miyoshi G, Hjerling-Leffler J, Karayannis T, Sousa VH, Butt SJB, Battiste J, Johnson JE, Machold RP, Fishell G. 2010. Genetic fate mapping reveals that the caudal ganglionic eminence produces a large and diverse population of superficial cortical interneurons. J Neurosci 30:1582-1594.
61. Molyneaux BJ, Arlotta P, Hirata T, Hibi M, Macklis JD. 2005. Fezl is required for the birth and specification of corticospinal motor neurons. Neuron 47:817-831.
62. Molyneaux BJ, Arlotta P, Menezes JRL, Macklis JD. 2007. Neuronal subtype specification in the cerebral cortex. Nat Rev Neurosci 8:427-437.
63. Ni JZ, Grate L, Donohue JP, Preston C, Nobida N, O'Brien G, Shiue L, Clark TA, Blume JE, Ares M. 2007. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev 21:708-718.
64. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
65. O'Leary DD., Nakagawa Y. 2002. Patterning centers, regulatory genes and extrinsic mechanisms controlling arealization of the neocortex. Curr Opin Neurobiol 12:14-25.
66. Owen N, Zhou H, Malygin AA, Sangha J, Smith LD, Muntoni F, Eperon IC. 2011. Design principles for bifunctional targeted oligonucleotide enhancers of splicing. Nucleic Acids Res 39:7194-7208.
67. Raj B, O'Hanlon D, Vessey JP, Pan Q, Ray D, Buckley NJ, Miller FD, Blencowe BJ. 2011. Cross-regulation between an alternative splicing activator and a transcription repressor controls neurogenesis. Mol Cell 43:843-850.
68. Rallu M, Corbin JG, Fishell G. 2002. Parsing the prosencephalon. Nat Rev Neurosci 3:943-951.
69. Riedl SJ, Salvesen GS. 2007. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8:405-413.
70. Rubenstein JLR, Anderson S, Shi L, Miyashita-Lin E, Bulfone A, Hevner R. 1999. Genetic control of cortical regionalization and connectivity. Cereb Cortex 9:524-532.
71. Sanford JR, Ellis J, Cáceres JF. 2005. Multiple roles of arginine/serine-rich splicing factors in RNA processing. Biochem Soc Trans 33:443-446.
72. Shen H, Green MR. 2004. A pathway of sequential arginine-serine-rich domain-splicing signal interactions during mammalian spliceosome assembly. Mol Cell 16:363-373.
73. Shen H, Green MR. 2007. RS domain-splicing signal interactions in splicing of U12-type and U2-type introns. Nat Struct Mol Biol 14:597-603.
74. Shen H, Zheng X, Luecke S, Green MR. 2010. The U2AF35-related protein Urp contacts the 3′ splice site to promote U12-type intron splicing and the second step of U2-type intron splicing. Genes Dev 24:2389-2394.
75. Shepard PJ, Hertel KJ. 2009. The SR protein family. Genome Biol 10:242.
76. Staknis D, Reed R. 1994. SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol Cell Biol 14:7670-7682.
77. Stoilov P, Daoud R, Nayler O, Stamm S. 2004. Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum Mol Genet 13:509-524.
78. Taylor BJ, Villella A, Ryner LC, Baker BS, Hall JC. 1994. Behavioral and neurobiological implications of sex-determining factors in Drosophila. Dev Genet 15:275-296.
79. Vaccarino FM, Schwartz ML, Raballo R, Nilsen J, Rhee J, Zhou M, Doetschman T, Coffin JD, Wyland JJ, Hung Y-TE. 1999. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci 2:485-485.
80. Visel A, Thaller C, Eichele G. 2004. GenePaint.org: an atlas of gene expression patterns in the mouse embryo. Nucleic Acids Res 32:D552-D556.
81. Volvert M-L, Rogister F, Moonen G, Malgrange B, Nguyen L. 2012. MicroRNAs tune cerebral cortical neurogenesis. Cell Death Differ 19:1573-1581.
82. Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y, Hitomi J, Yamamoto T, Utsuyama M, Niwa O, et al. 2003. Bcl11b is required for differentiation and survival of αβ T lymphocytes. Nat Immunol 4:533-539.
83. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476.
84. Wang J, Manley JL. 1995. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1:335-346.
85. Wang J, Takagaki Y, Manley JL. 1996. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes Dev 10:2588-2599.
86. Wang Y, Wang J, Gao L, Lafyatis R, Stamm S, Andreadis A. 2005. Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c·SRp55 complex that either recruits or antagonizes htra2β1. J Biol Chem 280:14230-14239.
87. Watermann DO, Tang Y, zur Hausen A, Jäger M, Stamm S, Stickeler E. 2006. Splicing factor Tra2-β1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res 66:4774-4780.
88. Wilson AC, Peterson MG, Herr W. 1995. The HCF repeat is an unusual proteolytic cleavage signal. Genes Dev 9:2445-2458.
89. Wirth B, Garbes L, Riessland M. 2013. How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches. Curr Opin Genet Dev (in press).
90. Wu JY, Maniatis T. 1993. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75:1061-1070.
91. Zahler AM, Neugebauer KM, Lane WS, Roth MB. 1993. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260:219-222.
92. Zheng S, Gray EE, Chawla G, Porse BT, O'Dell TJ, Black DL. 2012. PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. Nat Neurosci 15:381-388.
93. Zhong X-Y, Wang P, Han J, Rosenfeld MG, Fu X-D. 2009. SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 35:1-10.